Associations of gut-floradependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults

被引:237
|
作者
Chen, Yu-ming [1 ]
Liu, Yan [1 ]
Zhou, Rui-fen [1 ]
Chen, Xiao-ling [1 ]
Wang, Cheng [1 ]
Tan, Xu-ying [1 ]
Wang, Li-jun [2 ]
Zheng, Rui-dan [3 ]
Zhang, Hong-wei [4 ]
Ling, Wen-hua [1 ]
Zhu, Hui-lian [1 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China
[2] Jinan Univ, Fac Publ Hlth, Sch Med, Guangzhou 510632, Guangdong, Peoples R China
[3] Xiamen Univ, Affiliated Dongnan Hosp, Res & Therapy Ctr Liver Dis, Zhangzhou 363000, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510120, Guangdong, Peoples R China
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
中国国家自然科学基金;
关键词
HEPATIC STEATOSIS; PROGNOSTIC VALUE; PLASMA CHOLINE; MICROBIOTA; PHOSPHATIDYLCHOLINE; SUPPLEMENTATION; STEATOHEPATITIS; DIAGNOSIS; RISK; DIET;
D O I
10.1038/srep19076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many studies suggest that trimethylamine-N-oxide (TMAO), a gut-flora-dependent metabolite of choline, contributes to the risk of cardiovascular diseases, but little is known for non-alcoholic fatty liver disease (NAFLD). We examined the association of circulating TMAO, choline and betaine with the presence and severity of NAFLD in Chinese adults. We performed a hospital-based case-control study (CCS) and a cross-sectional study (CSS). In the CCS, we recruited 60 biopsy-proven NAFLD cases and 35 controls (18-60 years) and determined serum concentrations of TMAO, choline and betaine by HPLC-MS/MS. For the CSS, 1,628 community-based adults (40-75 years) completed the blood tests and ultrasonographic NAFLD evaluation. In the CCS, analyses of covariance showed adverse associations of ln-transformed serum levels of TMAO, choline and betaine/choline ratio with the scores of steatosis and total NAFLD activity (NAS) (all P-trend < 0.05). The CSS revealed that a greater severity of NAFLD was independently correlated with higher TMAO but lower betaine and betaine/choline ratio (all Ptrend < 0.05). No significant choline-NAFLD association was observed. Our findings showed adverse associations between the circulating TMAO level and the presence and severity of NAFLD in hospitaland community-based Chinese adults, and a favorable betaine-NAFLD relationship in the communitybased participants.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
    Yu-ming Chen
    Yan Liu
    Rui-fen Zhou
    Xiao-ling Chen
    Cheng Wang
    Xu-ying Tan
    Li-jun Wang
    Rui-dan Zheng
    Hong-wei Zhang
    Wen-hua Ling
    Hui-lian Zhu
    [J]. Scientific Reports, 6
  • [2] Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine
    Shi, Chunxia
    Pei, Maohua
    Wang, Yao
    Chen, Qian
    Cao, Pan
    Zhang, Luyi
    Guo, Jin
    Deng, Wei
    Wang, Luwen
    Li, Xun
    Gong, Zuojiong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 594 : 1 - 7
  • [3] Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease
    Ma, Rong
    Shi, Guangying
    Li, Yanfang
    Shi, Han
    [J]. BRITISH JOURNAL OF NUTRITION, 2024, 131 (11) : 1915 - 1923
  • [4] Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK
    Yang, Bingmo
    Tang, Guomin
    Wang, Mengting
    Ni, Yifan
    Tong, Jiali
    Hu, Chunyan
    Zhou, Ming
    Jiao, Kailin
    Li, Zhong
    [J]. TOXICOLOGY LETTERS, 2024, 400 : 93 - 103
  • [5] Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
    Wang, Zeneng
    Tang, W. H. Wilson
    Buffa, Jennifer A.
    Fu, Xiaoming
    Britt, Earl B.
    Koeth, Robert A.
    Levison, Bruce S.
    Fan, Yiying
    Wu, Yuping
    Hazen, Stanley L.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (14) : 904 - 910
  • [6] Gut microbiota and non-alcoholic fatty liver disease
    Abenavoli, Ludovico
    Procopio, Anna C.
    Scarpellini, Emidio
    Polimeni, Natale
    Aquila, Isabella
    Larussa, Tiziana
    Boccuto, Luigi
    Luzza, Francesco
    [J]. MINERVA GASTROENTEROLOGY, 2021, 67 (04): : 339 - 347
  • [7] Gut microbiota and non-alcoholic fatty liver disease
    Paraskevas Gkolfakis
    George Dimitriadis
    Konstantinos Triantafyllou
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (06) : 572 - 581
  • [8] Gut microbiota and non-alcoholic fatty liver disease
    Gkolfakis, Paraskevas
    Dimitriadis, George
    Triantafyllou, Konstantinos
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (06) : 572 - 581
  • [9] Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Grabherr, Felix
    Grander, Christoph
    Effenberger, Maria
    Adolph, Timon Erik
    Tilg, Herbert
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [10] Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model
    Bahramirad, Zhila
    Moloudi, Mohammad Raman
    Moradzad, Mohammad
    Abdollahi, Alina
    Vahabzadeh, Zakaria
    [J]. BIOCHEMICAL GENETICS, 2024,